Lessons learned from recent cardiovascular clinical trials: Part II.
Open Access
- 13 August 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (7), 880-886
- https://doi.org/10.1161/01.cir.0000023220.26465.89
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Monitoring and ensuring safety during clinical research.JAMA, 2001
- The Role of an Independent Statistical Analysis Center in the Institutes of Health ModelDrug Information Journal, 2001
- Protecting Research Subjects — What Must Be DoneNew England Journal of Medicine, 2000
- Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureJAMA, 2000
- Oversight Mechanisms for Clinical ResearchScience, 2000
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Rationale, Design, and Organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF)The American Journal of Cardiology, 1997
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Organization, review, and administration of cooperative studies (greenberg report): A report from the heart special project committee to the National Advisory heart council, May 1967Controlled Clinical Trials, 1988
- Letter to the editorsAtherosclerosis, 1978